| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |